His therapy has achieved remarkable results, with no tumor growth post-treatment and a disease control rate of 70-80%. His team is now advancing research on cancer vaccines, aiming to initiate ...

The large inflow of cash from Comirnaty gross profits in 2021-22 has further secured BioNTech's financial health. Outside of BioNTech’s covid-19 vaccine candidates, we think the earliest approval ...

Merck’s MRK stock has declined 14.4% in the past six months against an increase of 9.7% for the Large Cap Pharmaceuticals ...

A 1-dose human papillomavirus (HPV) vaccination program is projected to prevent a similar number of cervical cancers as a 2-dose program.

Cancer vaccines train the immune system to combat foreign invaders like tumours, enhancing the body's ability to recognize ...

A new chemotherapy regimen significantly boosts survival rates in cervical cancer patients and reduces the risk of death by ...

On September 10, experts across disciplines, from infectious disease clinicians to regulators to representatives from the pharmaceutical industry, convened at the inaugural ImmunOptimize workshop in ...

Immunotherapy and precision medicine show promise in better fighting cancer. What else does the research tell us?

And FDA said that Boston Scientific has again issued new instructions for its Obsidio Conformable Embolic after 15 injuries ...

The remarkable surge in the Intratumoral Cancer Therapies market is primarily attributed to the favorable regulatory ...

The biotech industry is buzzing with exciting changes, and a lot of it is thanks to one company: Moderna. Known for its COVID ...